From January 1, 2024 to February 2, 2024, the company has repurchased 4,017,200 shares, representing 1.73% for CNY 38.41 million. With this, the company has completed the repurchase of 4,017,200 shares, representing 1.73% for CNY 38.41 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 CNY | -0.36% |
|
-4.49% | -33.39% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.39% | 247M | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.